Atlas Trials

Determination of the Optimal Volume of 0.5% Bupivacaine Liposome in Single-Injection Interscalene Brachial Plexus Block: A Bayesian Phase I/II Trial

Clinical trial NCT06972680 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06972680
Sponsor
Affiliated Hospital of Jiaxing University
Status
ENROLLING_BY_INVITATION
Study type
OBSERVATIONAL
Shoulder Arthroscopy
Start date
2025-05-01
Primary completion
2027-12-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.